1. Oxidative Stress Is Progressively Enhanced With Advancing Stages of CKD 
Evangelia Dounousi, MD, Eleni Papavasiliou, MSc, Areti Makedou, MD, Kyriakos Ioannou, MD, Konstantinos P. Katopodis, MD, Alexandros Tselepis, MD, PhD, Kostas C. Siamopoulos, MSc, MD, FRSH, Dimitrios Tsakiris, MD, PhD (Glasgow) 
American Journal of Kidney Diseases 
Volume 48, Issue 5, Pages (November 2006)
DOI: /j.ajkd
Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

2. Fig 1
Distribution of the 87 patients and mean eGFRs in CKD stages 1 to 4. To convert eGFR in mL/min to mL/s, multiply by
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

3. Fig 2
Mean plasma 8-epiPGF2a levels in 87 patients with CKD stages 1 to 4 (ANOVA P < 0.001).
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

4. Fig 3
Correlation of eGFR with plasma 8-epiPGF2a levels in 87 patients. To convert eGFR in mL/min to mL/s, multiply by
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

5. Fig 4
Mean serum TΑS levels in 87 patients with CKD stages 1 to 4 (ANOVA P < 0.009).
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

6. Fig 5
Correlation of eGFR with serum TAS levels in 87 patients. To convert eGFR in mL/min to mL/s, multiply by
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

7. Fig 6
Correlation of serum TAS and uric acid levels in 87 patients. To convert uric acid in mg/dL to μmol/L, multiply by
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions